{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:55:04Z","timestamp":1793058904054,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jacl.2013.03.001","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T00:05:01Z","timestamp":1363219501000},"page":"472-483","source":"Crossref","is-referenced-by-count":223,"title":["Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education"],"prefix":"10.1016","volume":"7","author":[{"given":"Melissa Y.","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot A.","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2013.03.001_bib1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2013.03.001_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2013.03.001_bib3","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000312871","article-title":"Selection bias and information bias in clinical research","volume":"115","author":"Tripepi","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jacl.2013.03.001_bib4","series-title":"Randomized Controlled Trials: A User's Guide","author":"Jadad","year":"1998"},{"key":"10.1016\/j.jacl.2013.03.001_bib5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"issue":"9326","key":"10.1016\/j.jacl.2013.03.001_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20.536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2013.03.001_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2013.03.001_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.amjcard.2005.04.019","article-title":"Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations","volume":"96","author":"Davidson","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2013.03.001_bib9","first-page":"109","article-title":"Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol\u2013United States, 1999-2002 and 2005-200","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacl.2013.03.001_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11886-011-0221-2","article-title":"Predictors of statin adherence","volume":"13","author":"Mauskop","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacl.2013.03.001_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MLR.0b013e3181c132ad","article-title":"Patient, physician, and payment predictors of statin adherence","volume":"48","author":"Chan","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.jacl.2013.03.001_bib12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of non-adherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacl.2013.03.001_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s11606-010-1424-8","article-title":"Adherence to cardiovascular disease medications: does patient-provider race\/ethnicity and language concordance matter?","volume":"25","author":"Traylor","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacl.2013.03.001_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding Statin Use in America and Gaps in Patient Education (USAGE): an Internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2013.03.001_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2013.03.001_bib16","unstructured":"U.S. Census Bureau: State and country quickfacts. Available at: http:\/\/quickfacts.census.gov\/qfd\/states\/00000.html. Accessed September 30,\u00a02012."},{"key":"10.1016\/j.jacl.2013.03.001_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2013.03.001_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clinthera.2011.12.011","article-title":"Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis","volume":"34","author":"Esposti","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacl.2013.03.001_bib19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.amjcard.2011.01.052","article-title":"Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations","volume":"107","author":"Pittman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2013.03.001_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO Study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacl.2013.03.001_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0025-6196(11)60897-5","article-title":"Toward \u201cpain-free\u201d statin prescribing: A clinical algorithm for diagnosis and management of myalgias","volume":"83","author":"Jacobson","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacl.2013.03.001_bib22","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1517\/14656560903376186","article-title":"Non-adherence to statin therapy: a major challenge for preventive cardiology","volume":"10","author":"Bates","year":"2009","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.jacl.2013.03.001_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/clp.11.57","article-title":"Avoiding statin myopathy: understanding key drug interactions","volume":"6","author":"Harper","year":"2011","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.jacl.2013.03.001_bib24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2013.03.001_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pec.2006.09.013","article-title":"The physician-patient working alliance","volume":"66","author":"Fuertes","year":"2007","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacl.2013.03.001_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1185\/03007990802619425","article-title":"The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease","volume":"25","author":"McHorney","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacl.2013.03.001_bib27","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.clinthera.2009.11.030","article-title":"Validity of\u00a0the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims","volume":"31","author":"McHorney","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacl.2013.03.001_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.7205\/MILMED-D-09-00062","article-title":"Provider adherence to clinical guidelines related to lipid-lowering medications","volume":"175","author":"Cohen","year":"2010","journal-title":"Mil Med"},{"key":"10.1016\/j.jacl.2013.03.001_bib29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","article-title":"Suboptimal statin adherence and discontinuation in primary and secondary prevention populations","volume":"19","author":"Ellis","year":"2004","journal-title":"J Gen Intern Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287413000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287413000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T23:46:29Z","timestamp":1562802389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287413000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1933287413000615"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2013.03.001","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}